4.7 Article

Redox Regulation of Soluble Epoxide Hydrolase by 15-Deoxy-Δ-Prostaglandin J2 Controls Coronary Hypoxic Vasodilation

Journal

CIRCULATION RESEARCH
Volume 108, Issue 3, Pages 324-334

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCRESAHA.110.235879

Keywords

15-deoxy prostaglandin J(2), soluble epoxide hydrolase; redox signaling; hypoxia

Funding

  1. Medical Research Council
  2. British Heart Foundation
  3. American Heart Association [SDG 0635361N]
  4. National Institute of Environmental Health Sciences [ES02710, P42 ES04699]
  5. Department of Health through a National Institute for Health Research Comprehensive Biomedical Research Centre
  6. German Federal Ministry of Education and Research National Genome Research Network (BMBF NGFN)-Plus Heart Failure Network
  7. British Heart Foundation [PG/10/98/28655, FS/08/002/24537] Funding Source: researchfish
  8. Medical Research Council [G0700320, G0600785] Funding Source: researchfish
  9. MRC [G0600785, G0700320] Funding Source: UKRI

Ask authors/readers for more resources

Rationale: 15-Deoxy-Delta-prostaglandin (15d-PG)J(2) is an electrophilic oxidant that dilates the coronary vasculature. This lipid can adduct to redox active protein thiols to induce oxidative posttranslational modifications that modulate protein and tissue function. Objective: To investigate the role of oxidative protein modifications in 15d-PGJ(2)-mediated coronary vasodilation and define the distal signaling pathways leading to enhanced perfusion. Methods and Results: Proteomic screening with biotinylated 15d-PGJ(2) identified novel vascular targets to which it adducts, most notably soluble epoxide hydrolase (sEH). 15d-PGJ(2) inhibited sEH by specifically adducting to a highly conserved thiol (Cys521) adjacent to the catalytic center of the hydrolase. Indeed a Cys521Ser sEH redox-dead mutant was resistant to 15d-PGJ(2)-induced hydrolase inhibition. 15d-PGJ(2) dilated coronary vessels and a role for hydrolase inhibition was supported by 2 structurally different sEH antagonists each independently inducing vasorelaxation. Furthermore, 15d-PGJ(2) and sEH antagonists also increased coronary effluent epoxyeicosatrienoic acids consistent with their vasodilatory actions. Indeed 14,15-EET alone induced relaxation and 15d-PGJ(2)-mediated vasodilation was blocked by the EET receptor antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EEZE). Additionally, the coronary vasculature of sEH-null mice was basally dilated compared to wild-type controls and failed to vasodilate in response to 15d-PGJ(2). Coronary vasodilation to hypoxia in wild-types was accompanied by 15d-PGJ(2) adduction to and inhibition of sEH. Consistent with the importance of hydrolase inhibition, sEH-null mice failed to vasodilate during hypoxia. Conclusion: This represents a new paradigm for the regulation of sEH by an endogenous lipid, which is integral to the fundamental physiological response of coronary hypoxic vasodilation. (Circ Res. 2011;108:324-334.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available